112 related articles for article (PubMed ID: 15630279)
1. Red wine polyphenolics suppress the secretion and the synthesis of Apo B48 from human intestinal CaCo-2 cells.
Takechi R; Hiramatsu N; Mamo JC; Pal S
Biofactors; 2004; 22(1-4):181-3. PubMed ID: 15630279
[TBL] [Abstract][Full Text] [Related]
2. Red wine polyphenolics suppress the secretion of ApoB48 from human intestinal CaCo-2 cells.
Pal S; Ho SS; Takechi R
J Agric Food Chem; 2005 Apr; 53(7):2767-72. PubMed ID: 15796623
[TBL] [Abstract][Full Text] [Related]
3. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells.
Pal S; Ho N; Santos C; Dubois P; Mamo J; Croft K; Allister E
J Nutr; 2003 Mar; 133(3):700-6. PubMed ID: 12612140
[TBL] [Abstract][Full Text] [Related]
4. Polyphenolics and fat absorption.
Pal S; Naissides M; Mamo J
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):324-6. PubMed ID: 14970839
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol esters regulate apoB48 secretion in CaCo2 cells.
Pal S; Allister E; Thomson A; Mamo JC
Atherosclerosis; 2002 Mar; 161(1):55-63. PubMed ID: 11882317
[TBL] [Abstract][Full Text] [Related]
6. Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells.
Ho SS; Pal S
Atherosclerosis; 2005 Sep; 182(1):29-36. PubMed ID: 16115472
[TBL] [Abstract][Full Text] [Related]
7. Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease.
Dane-Stewart CA; Watts GF; Pal S; Chan D; Thompson P; Hung J; Mamo JC
Metabolism; 2003 Oct; 52(10):1279-86. PubMed ID: 14564679
[TBL] [Abstract][Full Text] [Related]
8. Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells.
Funatsu T; Suzuki K; Goto M; Arai Y; Kakuta H; Tanaka H; Yasuda S; Ida M; Nishijima S; Miyata K
Atherosclerosis; 2001 Jul; 157(1):107-15. PubMed ID: 11427209
[TBL] [Abstract][Full Text] [Related]
9. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
[TBL] [Abstract][Full Text] [Related]
10. MTP gene polymorphisms and postprandial lipemia in familial combined hyperlipidemia: effects of treatment with atorvastatin.
Klop B; Verseyden C; Ribalta J; Salazar J; Masana L; Cabezas MC
Clin Investig Arterioscler; 2014; 26(2):49-57. PubMed ID: 24378322
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
[TBL] [Abstract][Full Text] [Related]
12. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
[TBL] [Abstract][Full Text] [Related]
13. The effect of acute red wine polyphenol consumption on postprandial lipaemia in postmenopausal women.
Naissides M; Mamo JC; James AP; Pal S
Atherosclerosis; 2004 Dec; 177(2):401-8. PubMed ID: 15530916
[TBL] [Abstract][Full Text] [Related]
14. Postprandial apolipoprotein B48-and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism?
Battula SB; Fitzsimons O; Moreno S; Owens D; Collins P; Johnson A; Tomkin GH
Metabolism; 2000 Aug; 49(8):1049-54. PubMed ID: 10954025
[TBL] [Abstract][Full Text] [Related]
15. Red wine polyphenols, in the absence of alcohol, reduce lipid peroxidative stress in smoking subjects.
Abu-Amsha Caccetta R; Burke V; Mori TA; Beilin LJ; Puddey IB; Croft KD
Free Radic Biol Med; 2001 Mar; 30(6):636-42. PubMed ID: 11295361
[TBL] [Abstract][Full Text] [Related]
16. The effect of chronic consumption of red wine on cardiovascular disease risk factors in postmenopausal women.
Naissides M; Mamo JC; James AP; Pal S
Atherosclerosis; 2006 Apr; 185(2):438-45. PubMed ID: 16095600
[TBL] [Abstract][Full Text] [Related]
17. Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients.
Ikejiri A; Hirano T; Murayama S; Yoshino G; Gushiken N; Hyodo T; Taira T; Adachi M
Metabolism; 2004 Sep; 53(9):1113-7. PubMed ID: 15334369
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
Moon JH; Kang SB; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Metabolism; 2011 Jul; 60(7):930-40. PubMed ID: 20951395
[TBL] [Abstract][Full Text] [Related]
19. Insulin decreases the secretion of apoB-100 from hepatic HepG2 cells but does not decrease the secretion of apoB-48 from intestinal CaCo-2 cells.
Allister EM; Pal S; Thomson AM; Helmerhorst E; Mamo JC
J Biomed Sci; 2004; 11(6):789-98. PubMed ID: 15591776
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
